30 Stocks Moving In Monday's Mid-Day Session

Gainers

  • Transenterix Inc TRXC shares jumped 83.3 percent to $2.63 following FDA 510(k) clearance for its Senhance System.
  • Leading Brands, Inc (USA) LBIX shares gained 36.6 percent to $3.10 after climbing 68.15 percent on Friday. Leading Brands reported a Q2 loss of $0.25 per share on revenue of $509,000.
  • Exelixis, Inc. EXEL shares surged 29 percent to $31.92 after the company announced an encouraging update for its CABOMETYX (cabozantinib) therapy for the treatment of patients with advanced hepatocellular carcinoma.
  • Ruby Tuesday, Inc. RT shares climbed 18.8 percent to $2.37 after the company agreed to be acquired for $2.40 per share in cash.
  • TDH Holdings Inc PETZ shares gained 15.9 percent to $28.70.
  • Net Element International Inc NETE shares rose 15.6 percent to $6.08. On Friday, Net Element disclosed that e-commerce and value-added integrated services volumes rose 134 percent year-over-year during the first half of 2017.
  • Gravity Co., LTD. (ADR) GRVY shares gained 13 percent to $41.79.
  • Determine Inc DTRM shares climbed 11 percent to $2.33. B. Riley initiated coverage on Determine with a Buy rating.
  • Five Prime Therapeutics Inc FPRX shares surged 9 percent to $47.33. BMO Capital upgrades Five Prime Therapeutics from Market Perform to Outperform.
  • Helios and Matheson Analytics Inc HMNY shares gained 8 percent to $22.03 after slipping 0.49 percent on Friday.
  • Hudbay Minerals Inc HBM shares gained 7.6 percent to $8.55 after slipping 1.24 percent on Friday.
  • Health Insurance Innovations Inc HIIQ gained 7.4 percent to $20.30 after the company issued a strong forecast for the third quarter and announced a $50 million buyback plan.
  • Aratana Therapeutics Inc PETX climbed 6.9 percent to $6.68 after the company announced plans to launch ENTYCE in the United States.
  • BEST Inc (ADR) BSTI gained 5 percent to $11.96. KeyBanc initiated coverage on BEST with an Overweight rating, while Stifel Nicolaus initiated coverage of the stock with a Buy rating.
  • bluebird bio Inc BLUE shares climbed 4.6 percent to $137.70. Evercore ISI Group upgraded bluebird bio from In-Line to Outperform.
  • Groupon Inc GRPN shares rose 3.6 percent to $4.80. Cowen & Co. upgraded Groupon from Underperform to Market Perform.

 

 

Losers

  • Natural Health Trends Corp. NHTC shares tumbled 19.2 percent to $20.16. Natural Health Trends reported Q3 preliminary sales of $40.1 million, versus $70.7 million in prior year quarter.
  • China Lending Corp CLDC shares dipped 14 percent to $4.42.
  • Nuverra Environmental Solutions, Inc. NES shares fell 13.8 percent to $9.70.
  • Fennec Pharmaceuticals Inc FENC shares dropped 12.3 percent to $10.56 after the company reported that its Phase 3 SIOPEL study met its primary endpoint.
  • TG Therapeutics Inc TGTX shares dropped 12.1 percent to $9.68. The FDA stated that GENUINE 3 results will cause an issue for getting an accelerated approval.
  • MACOM Technology Solutions Holdings Inc MTSI shares fell 11.5 percent to $36.80. Stifel Nicolaus downgrades MACOM Technology from Buy to Hold.
  • Smart Global Holdings Inc SGH shares declined 11.1 percent to $29.97.
  • Ampio Pharmaceuticals Inc AMPE shares dipped 9.4 percent to $0.960. Ampio Pharma priced $6.75 millio registered direct offering at $0.875 per share.
  • eGain Corp EGAN shares slipped 7.4 percent to $3.15.
  • Antares Pharma Inc ATRS shares declined 6.5 percent to $2.17 after tumbling 37.80 percent on Friday.
  • Sears Holdings Corp SHLD shares dropped 6.4 percent to $6.34 after the company disclosed that Bruce Berkowitz decided to step down from the Sears board.
  • Albireo Pharma, Inc. ALBOshares fell 6.3 percent to $25.30 after surging 12.51 percent on Friday.
  • Imperva Inc IMPV declined 6 percent to $41.00. Piper Jaffray downgraded Imperva from Overweight to Neutral.
  • Deckers Outdoor Corp DECK fell 3.3 percent to $63.65. Susquehanna downgraded Deckers Outdoor from Neutral to Negative.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!